Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ping An Biomedical CoPASW -6.49%17 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2025. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 860 Manufacturing - Apparel & Accessories companies, Ping An Biomedical Co ranks worse than 116278.95% on this metric.
During the past 12 months, Ping An Biomedical Co's average EBITDA Per Share Growth Rate was -3733.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ping An Biomedical Co was -69.70% per year. The lowest was -69.70% per year. And the median was -69.70% per year.
Ping An Biomedical Co (NAS:PASW) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Ping An Biomedical Co 3-Year EBITDA Growth Rate Related Terms
PASW vs DXYN, CULP, UFI: 3-Year EBITDA Growth Rate Comparison
For the Textile Manufacturing subindustry, Ping An Biomedical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ping An Biomedical Co 3-Year EBITDA Growth Rate vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Ping An Biomedical Co's 3-Year EBITDA Growth Rate falls into.
Ping An Biomedical Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Ping An Biomedical Co (PASW) has a 3-Year EBITDA Growth Rate of 0.00% as of Sep. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Ping An Biomedical Co and its competitors. According to the industry distribution chart, Ping An Biomedical Co ranks #999999 out of 860 companies in the Manufacturing - Apparel & Accessories industry.
Is Ping An Biomedical Co's 3-Year EBITDA Growth Rate too high?
Ping An Biomedical Co's current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Ping An Biomedical Co ranks #999999 out of 860 companies in the Manufacturing - Apparel & Accessories industry, which is in the bottom quartile relative to peers. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's 3-Year EBITDA Growth Rate compare to DXYN and CULP?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Ping An Biomedical Co ranks #999999 out of 860 companies for 3-Year EBITDA Growth Rate. This places Ping An Biomedical Co in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 1.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Manufacturing - Apparel & Accessories company?
The median 3-Year EBITDA Growth Rate among Manufacturing - Apparel & Accessories companies is 1.50, based on 860 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Ping An Biomedical Co and its competitors. For the Manufacturing - Apparel & Accessories industry, the median 3-Year EBITDA Growth Rate is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ping An Biomedical Co's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current 3-Year EBITDA Growth Rate of 0.00%. The current 3-Year EBITDA Growth Rate is 0.00%. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current 3-Year EBITDA Growth Rate is 0.00% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score
Get the complete analysis for PASW
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PASW has been successfully added to your 
